| Trichothiodystrophy: from basic mechanisms to clinical implications M Stefanini, E Botta, M Lanzafame, D Orioli DNA repair 9 (1), 2-10, 2010 | 126 | 2010 |
| Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study CKY Ng, GG Di Costanzo, N Tosti, V Paradiso, M Coto-Llerena, ... Annals of Oncology 29 (5), 1286-1291, 2018 | 90 | 2018 |
| The role of long non-coding RNAs in hepatocarcinogenesis M Lanzafame, G Bianco, LM Terracciano, CKY Ng, S Piscuoglio International journal of molecular sciences 19 (3), 682, 2018 | 84 | 2018 |
| Functional and clinical relevance of novel mutations in a large cohort of patients with Cockayne syndrome N Calmels, E Botta, N Jia, H Fawcett, T Nardo, Y Nakazawa, ... Journal of medical genetics 55 (5), 329-343, 2018 | 63 | 2018 |
| GTF2E2 mutations destabilize the general transcription factor complex TFIIE in individuals with DNA repair-proficient trichothiodystrophy C Kuschal, E Botta, D Orioli, JJ Digiovanna, S Seneca, K Keymolen, ... The American Journal of Human Genetics 98 (4), 627-642, 2016 | 59 | 2016 |
| High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models L Quagliata, C Quintavalle, M Lanzafame, MS Matter, C Novello, ... Laboratory investigation 98 (1), 95-105, 2018 | 50 | 2018 |
| Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma V Kancherla, S Abdullazade, MS Matter, M Lanzafame, L Quagliata, ... Frontiers in Genetics 9, 2, 2018 | 43 | 2018 |
| TFIIH-dependent MMP-1 overexpression in trichothiodystrophy leads to extracellular matrix alterations in patient skin L Arseni, M Lanzafame, E Compe, P Fortugno, A Afonso-Barroso, ... Proceedings of the National Academy of Sciences 112 (5), 1499-1504, 2015 | 32 | 2015 |
| Overexpression of parkin rescues the defective mitochondrial phenotype and the increased apoptosis of Cockayne Syndrome A cells B Pascucci, M D’Errico, A Romagnoli, C De Nuccio, M Savino, ... Oncotarget 8 (61), 102852, 2017 | 30 | 2017 |
| Prevention of dsRNA‐induced interferon signaling by AGO1x is linked to breast cancer cell proliferation S Ghosh, JC Guimaraes, M Lanzafame, A Schmidt, AP Syed, ... The EMBO journal 39 (18), e103922, 2020 | 19 | 2020 |
| Diagnostic targeted sequencing panel for hepatocellular carcinoma genomic screening V Paradiso, A Garofoli, N Tosti, M Lanzafame, V Perrina, L Quagliata, ... The Journal of Molecular Diagnostics 20 (6), 836-848, 2018 | 18 | 2018 |
| Reference genes for gene expression analysis in proliferating and differentiating human keratinocytes M Lanzafame, E Botta, M Teson, P Fortugno, G Zambruno, M Stefanini, ... Experimental dermatology 24 (4), 314-316, 2015 | 17 | 2015 |
| From laboratory tests to functional characterisation of Cockayne syndrome M Lanzafame, B Vaz, T Nardo, E Botta, D Orioli, M Stefanini Mechanisms of Ageing and Development 134 (5-6), 171-179, 2013 | 14 | 2013 |
| Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms M Bombaci, E Pesce, A Torri, D Carpi, M Crosti, M Lanzafame, ... Liver International 39 (11), 2124-2135, 2019 | 12 | 2019 |
| The polyphenol/saponin-rich Rhus tripartita extract has an apoptotic effect on THP-1 cells through the PI3K/AKT/mTOR signaling pathway H Tlili, A Macovei, D Buonocore, M Lanzafame, H Najjaa, A Lombardi, ... BMC complementary medicine and therapies 21 (1), 153, 2021 | 9 | 2021 |
| SPANX-B and SPANX-C (Xq27 region) gene dosage analysis in Sicilian patients with melanoma M Salemi, P Bosco, F Calì, AE Calogero, PF Soma, A Galia, M Lanzafame, ... Melanoma Research 18 (4), 295-299, 2008 | 9 | 2008 |
| Cockayne syndrome group A and ferrochelatase finely tune ribosomal gene transcription and its response to UV irradiation M Lanzafame, G Branca, C Landi, M Qiang, B Vaz, T Nardo, D Ferri, ... Nucleic Acids Research 49 (19), 10911-10930, 2021 | 7 | 2021 |
| Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens H Montazeri, M Coto-Llerena, G Bianco, E Zangene, S Taha-Mehlitz, ... Nucleic acids research 49 (15), 8488-8504, 2021 | 4 | 2021 |
| Non-viral gene delivery of the oncotoxic protein NS1 for treatment of hepatocellular carcinoma D Witzigmann, P Grossen, C Quintavalle, M Lanzafame, SH Schenk, ... Journal of Controlled Release 334, 138-152, 2021 | 4 | 2021 |
| TFIIH stabilization recovers the DNA repair and transcription dysfunctions in thermo‐sensitive trichothiodystrophy M Lanzafame, T Nardo, R Ricotti, C Pantaleoni, S D'Arrigo, F Stanzial, ... Human Mutation 43 (12), 2222-2233, 2022 | 3 | 2022 |
Charlotte K Y NgHumanitas University and University of BernVerified email at unibe.ch
